Yellow Jersey Therapeutics is a startup based in Switzerland, most recent round Acquired, 1 tracked investor.
Yellow Jersey Therapeutics is a startup based in Switzerland. Yellow Jersey Therapeutics has been acquired. Brouky records 1 investor associated with the company.
Yellow Jersey Therapeutics develops bi-specific antibodies, including NM26, a treatment for atopic dermatitis, and was a wholly owned subsidiary of Numab Therapeutics before being acquired by Johnson & Johnson in 2024.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.